Boceprevir is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please or purchase a subscription.

Johns Hopkins Guides provide diagnosis, management, and treatment guidance for infectious diseases, diabetes, and psychiatric conditions. Explore these free sample topics:

Johns Hopkins Guides

~~ The first section of this topic is shown below ~~

INDICATIONS

FDA

Boceprevir is indicated for the treatment of HCV (genotype1, used in combination with peg-INF + ribavirin) in adult patients with compensated liver disease, including cirrhosis. Boceprevir may be used in either treatment-naïve patients or those who have failed previously interferon/ribavirin therapy.

~~ To view the remaining sections of this topic, please
or purchase a subscription ~~

Last updated: April 10, 2012